Latest papers

Proliferation of myoblast skeletal cells on three-dimensional supermacroporous cryogels.

Automating the expansion process of human skeletal muscle myoblasts with suppression of myotube formation.

Oleate protects against palmitate-induced insulin resistance in L6 myotubes.

Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.

Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute.

Controlled release of matrix metalloproteinase 1 with or without skeletal myoblasts transplantation improves cardiac function of rat hearts with chronic myocardial infarction.

Transplantation of progenitor cells and regeneration of damaged myocardium: more facts or doubts? Insights from experimental and clinical studies.

Evidence that Mechanosensors with Distinct Biomechanical Properties Allow for Specificity in Mechanotransduction

Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program.

Differentiation of multipotent mesenchymal precursors and skeletal myoblasts from human embryonic stem cells.

Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.

Shilianhua extract inhibits GSK-3 and promotes glucose metabolism

Improved diastolic function after myoblast transplantation in a model of ischemia-infarction

Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.

PRDM16: the interconvertible adipo-myocyte switch

Stem cell therapy for urethral sphincter regeneration.

Evidence for γ-actin as a Z disc component in skeletal myofibers

Comparison of intra-coronary cell transplantation after myocardial infarction: Autologous skeletal myoblasts versus bone marrow mesenchymal stem cells.

Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: report of a case.